Administration of insulin-like growth factor-I improves fatigue resistance of skeletal muscles from dystrophic mdx mice

Muscle and Nerve

Volumn 30, Issue 3, 2004, Pages 295-304

  Gregorevic, Paul ^a   Plant, David R ^a   Lynch, Gordon S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Calcium sensitivity; Insulin like growth factor I; Muscle fatigue; Muscle function; Muscular dystrophy

Indexed keywords

SOMATOMEDIN C; SUCCINATE DEHYDROGENASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAPHRAGM MUSCLE; DRUG EFFICACY; ENZYME ACTIVITY; EXTENSOR DIGITORUM LONGUS MUSCLE; FATIGUE; FUNCTIONAL ASSESSMENT; LOCOMOTION; MALE; MORPHOMETRICS; MOUSE; MUSCLE CELL; MUSCLE CONTRACTION; MUSCLE FUNCTION; MUSCLE ISOMETRIC CONTRACTION; MUSCLE MASS; MUSCLE METABOLISM; MUSCLE TWITCH; MUSCULAR DYSTROPHY; NONHUMAN; PHYSICAL CAPACITY; PRIORITY JOURNAL; QUALITY OF LIFE; SOLEUS MUSCLE;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE CONTRACTION; MUSCLE FATIGUE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; RECOMBINANT PROTEINS;

EID: 4243086931     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.20082     Document Type: Article

References (46)

1. Adams GR. Insulin-like growth factor in muscle growth and its potential abuse by athletes. Br J Sports Med 2000;34:412-413.
2. Adams GR, McCue SA. Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats. J Appl Physiol 1998;84: 1716-1722.
3. Bach LA. The insulin-like growth factor system: basic and clinical aspects. Aust N Z J Med 1999;29:355-361.
4. Bark TH, McNurlan MA, Lang CH, Garlick PJ. Increased protein synthesis after acute IGF-I or insulin infusion is localized to muscle in mice. Am J Physiol 1998;275:E118-E123.
5. Barton ER, Morris L, Musaro A, Rosenthal N, Sweeney HL. Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J Cell Biol 2002;157: 137-148.
6. Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N, Sweeney HL. Viral-mediated expression of insulin-like growth factor-I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci USA 1998;95:15603-15607.
7. Blanco CE, Sieck GC, Edgerton VR. Quantitative histochemical determination of succinic dehydrogenase activity in skeletal muscle fibres. Histochem J 1988;20:230-243.
8. 2+-activation properties of rat skeletal muscle fibers. Am J Physiol Cell Physiol 2000;279:C1564-C1577.
9. Chamberlain JS. Gene therapy of muscular dystrophy. Hum Mol Genet 2002;11:2355-2362.
10. Chin ER, Olson EN, Richardson JA, Yang Q, Humphries C, Shelton JM, Wu H, Bassel-Duby R, Williams RS. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev 1998;12:2499-2509.
11. Coleman ME, DeMayo F, Yin KC, Lee HM, Geske R, Montgomery C, Schwartz RJ. Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J Biol Chem 1995; 270:12109-12116.
12. De Luca A, Pierno S, Camerino C, Cocchi D, Camerino DC. Higher content of insulin-like growth factor-I in dystrophic mdx mouse: potential role in the spontaneous regeneration through an electrophysiological investigation of muscle function. Neuromuscul Disord 1999;9:11-18.
13. Delling U, Tureckova J, Lim HW, De Windt LJ, Rotwein P, Molkentin JD. A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression. Mol Cell Biol 2000;20:6600-6611.
14. Dunn JF, Tracey I, Radda GK. Exercise metabolism in Duchenne muscular dystrophy: a biochemical and [31P]-nuclear magnetic resonance study of mdx mice. Proc R Soc Lond [Biol] 1993;251:201-206.
15. Dupont-Versteegden EE, McCarter RJ. Differential expression of muscular dystrophy in diaphragm versus hindlimb muscles of mdx mice. Muscle Nerve 1992;15:1105-1110.
16. Engel AG, Franzini-Armstrong C, editors. Myology, 2nd ed. New York: McGraw-Hill; 1994. 2500 p.
17. Fang CH, Li BG, Wang JJ, Fischer JE, Hasselgren PO. Treatment of burned rats with insulin-like growth factor I inhibits the catabolic response in skeletal muscle. Am J Physiol 1998; 275:R1091-R1098.
18. Festoff BW. The preclinical rationale for the use of insulin-like growth factor-I in amyotrophic lateral sclerosis. Drugs Today 1998;34:65-77.
19. Fink RH, Stephenson DG, Williams DA. Potassium and ionic strength effects on the isometric force of skinned twitch muscle fibres of the rat and toad. J Physiol (Lond) 1986;370:317-337.
20. 2+ in single intact muscle fibres from transgenic mice. J Physiol (Lond) 2003;552:833-844.
21. Granchelli JA, Pollina C, Hudecki MS. Pre-clinical screening of drugs using the mdx mouse. Neuromuscul Disord 2000;10: 235-239.
22. Gregorevic P, Plant DR, Leeding KS, Bach LA, Lynch GS. Improved contractile function of the mdx dystrophic mouse diaphragm muscle following IGF-I administration. Am J Pathol 2002;161:2263-2272.
23. Hauser E, Hoger H, Bittner R, Widhalm K, Herkner K, Lubec G. Oxyradical damage and mitochondrial enzyme activities in the mdx mouse. Neuropediatrics 1995;26:260-262.
24. Hsu HH, Zdanowicz MM, Agarwal VR, Speiser PW. Expression of myogenic regulatory factors in normal and dystrophic mice: effects of IGF-I treatment. Biochem Mol Med 1997;60: 142-148.
25. Lewis MI, LoRusso TJ, Fournier M. Anabolic influences of insulin-like growth factor I and/or growth hormone on the diaphragm of young rats. J Appl Physiol 1997;82:1972-1978.
26. Lynch GS. Novel therapies for muscular dystrophy. Expert Opin Therap Patents 2001;11:587-601.
27. Lynch GS, Faulkner JA. Contraction-induced injury to single muscle fibers: velocity of stretch does not influence the force deficit. Am J Physiol Cell Physiol 1998;275:C1548-C1554.
28. Lynch GS, Cuffe SA, Plant DR, Gregorevic P. IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice. Neuromuscul Disord 2001;11:260-268.
29. Lynch GS, Hayes A, Lam MH, Williams DA. The effects of endurance exercise on dystrophic mdx mice. II. Contractile properties of skinned muscle fibres. Proc R Soc Lond [Biol] 1993;253:27-33.
30. Lynch GS, Hinkle RT, Chamberlain JS, Brooks SV, Faulkner JA. Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old. J Physiol (Lond) 2001;535: 591-600.
31. 2+ activation characteristics in skinned muscle fibre preparations with different proportions of myofibrillar isoforms. J Muscle Res Cell Motil 1995;16:65-78.
32. Musaro A, McCullagh K, Paul A, Houghton L, Dobrowolny G, Molinaro M, Barton ER, Sweeney HL, Rosenthal N. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 2001;27:195-200.
33. Musaro A, McCullagh KJA, Naya FJ, Olson EN, Rosenthal N. IGF-I induces skeletal myocyte hypertrophy though calcineurin in association with GATA-2 and NF-ATc1. Nature 1999;400:581-585.
34. Nakae Y, Stoward PJ, Shono M, Matsuzaki T. Localisation and quantification of dehydrogenase activities in single muscle fibres of mdx gastrocnemius. Histochem Cell Biol 1999;112: 427-436.
35. Plant DR, Lynch GS. Rigor force responses of permeabilized fibres from fast and slow skeletal muscles of aged rats. Clin Exp Pharmacol Physiol 2001;28:779-781.
36. Plant DR, Lynch GS. Depolarization-induced contraction and SR function in mechanically skinned muscle fibers from dystrophic mdx mice. Am J Physiol Cell Physiol 2003;285:C522-C528.
37. Sieck GC, Fournier M, Prakash YS, Blanco CE. Myosin phenotype and SDH enzyme variability among motor unit fibers. J Appl Physiol 1996;80:2179-2189.
38. Singleton JR, Feldman EL. Insulin-like growth factor-I in muscle metabolism and myotherapies. Neurobiol Dis 2001;8:541-554.
39. Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panettieri RA, Petrof B, Narusawa M, Leferovich JM, Sladky JT, Kelly AM. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 1991;352:536-539.
40. Vlachopapadopoulou E, Zachwieja JJ, Gertner JM, Manzione D, Bier DM, Matthews DE, Slonim AE. Metabolic and clinical response to recombinant human insulin-like growth factor I in myotonic dystrophy - a clinical research center study. J Clin Endocrinol Metab 1995;80:3715-3723.
41. 2+ in mouse skeletal muscle. Biophys J 2002;82:1338-1344.
42. 2+ channel gene expression. J Physiol (Lond) 1999;516:331-341.
43. Warren GL, Lowe DA, Armstrong RB. Measurement tools used in the study of eccentric contraction-induced injury. Sports Med 1999;27:43-59.
44. Williams DA, Head SI, Lynch GS, Stephenson DG. Contractile properties of skinned muscle fibres from young and adult normal and dystrophic (mdx) mice. J Physiol (Lond) 1993; 460:51-67.
45. Wingertzahn MA, Zdanowicz MM, Slonim AE. Insulin-like growth factor-I and high protein diet decrease calpain-mediated proteolysis in murine muscular dystrophy. Exp Biol Med 1998;218:244-250.
46. Zdanowicz MM, Moyse J, Wingertzahn MA, O'Connor M, Teichberg S, Slonim AE. Effect of insulin-like growth factor I in murine muscular dystrophy. Endocrinology 1995;136: 4880-4886.